Patents by Inventor Nathalie Gendron

Nathalie Gendron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9205122
    Abstract: Described herein is a composition comprising a combination of ginger and goldenrod for the prevention and/or treatment of cold and/or flu infection. Also described is a method of treating or preventing a cold and/or flu infection in a subject in need thereof comprising administering to the subject an effective amount of a composition comprising a combination of ginger and goldenrod.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: December 8, 2015
    Assignee: MARESINS PHARMA, INC.
    Inventors: Benoit Cyr, Johane Guay, Brigitte Page, Nathalie Gendron
  • Publication number: 20140093596
    Abstract: Extracts derived from plants of the Tsuga genus having anti-inflammatory and antimicrobial properties are provided. The Tsuga extracts are suitable for the treatment of inflammation, irritation and/or infection.
    Type: Application
    Filed: October 7, 2013
    Publication date: April 3, 2014
    Applicant: LUCAS MEYER COSMETICS INC.
    Inventors: Johane GUAY, Benoit CYR, Nathalie GENDRON, Brigitte PAGE
  • Publication number: 20120201911
    Abstract: Described herein is a composition comprising a combination of ginger and goldenrod for the prevention and/or treatment of cold and/or flu infection. Also described is a method of treating or preventing a cold and/or flu infection in a subject in need thereof comprising administering to the subject an effective amount of a composition comprising a combination of ginger and goldenrod.
    Type: Application
    Filed: October 22, 2010
    Publication date: August 9, 2012
    Applicant: BIOPHARMACOPAE INC.
    Inventors: Benoit Cyr, Johane Guay, Brigitte Page, Nathalie Gendron
  • Publication number: 20110311661
    Abstract: Plant extracts and dermatological formulations comprising one or more plant extracts that are capable of inhibiting one or more extracellular proteases selected from the group of: matrix metalloprotease-1 (MMP-1), matrix metalloprotease-2 (MMP-2), matrix metalloprotease-3 (MMP-3), matrix metalloprotease-9 (MMP-9) and human leukocyte elastase (HLE). A rapid method for screening plant extracts to identify those having the above activity that are suitable for incorporation into the dermatological formulations of the invention. The use of the plant extracts as dermatological agents suitable for the treatment or prevention of various dermatological conditions, including wrinkling or sagging of the skin, irradiation induced skin and/or hair damage, deepening of skin lines, elastotic changes in the skin, as well as for the routine care of the skin, hair and/or nails.
    Type: Application
    Filed: December 16, 2010
    Publication date: December 22, 2011
    Inventors: Stephen Behr, Philippe Duret, Nathalie Gendron, Johane Guay, Bernard Lavallee, Brigitte Page
  • Publication number: 20110177014
    Abstract: Extracts derived from plants of the Tsuga genus having anti-inflammatory and anti-microbial properties are provided. The Tsuga extracts are suitable for the treatment of inflammation, irritation and/or infection.
    Type: Application
    Filed: April 1, 2009
    Publication date: July 21, 2011
    Applicant: BIOPHARMACOPAE DESIGN INTERNATIONAL INC.
    Inventors: Johane Guay, Benoit Cyr, Nathalie Gendron, Brigitte Page
  • Publication number: 20070122492
    Abstract: The present invention provides for plant extracts and dermatological formulations comprising one or more plant extracts that are capable of inhibiting one or more extracellular proteases selected from the group of: matrix metalloprotease-1 (MMP-1), matrix metalloprotease-2 (MMP-2), matrix metalloprotease-3 (MMP-3), matrix metalloprotease-9 (MMP-9) and human leukocyte elastase (HLE). The present invention further provides for a rapid method for screening plant extracts to identify those having the above activity that are suitable for incorporation into the dermatological formulations of the invention. The invention also provides for the use of the plant extracts as dermatological agents suitable for the treatment or prevention of various dermatological conditions, including wrinkling or sagging of the skin, irradiation induced skin and/or hair damage, deepening of skin lines, elastotic changes in the skin, as well as for the routine care of the skin, hair and/or nails.
    Type: Application
    Filed: November 18, 2004
    Publication date: May 31, 2007
    Inventors: Stephen Behr, Philippe Duret, Nathalie Gendron, Johane Guay, Bernard Lavallee, Brigitte Page
  • Publication number: 20060269520
    Abstract: The invention features methods, compositions and kits for the treatment of degenerative disorders.
    Type: Application
    Filed: January 30, 2006
    Publication date: November 30, 2006
    Applicant: Children's Hospital of Eastern Ontario
    Inventors: Robert Korneluk, Catherine Tsilfidis, Peter Liston, Alex MacKenzie, George Robertson, Nathalie Gendron, James Waring, Doug Mahoney